Inicio › Cáncer de endometrio › Minnesota › Minneapolis
Ensayos clínicos de Cáncer de endometrio en Minneapolis, MN
18 estudios para Cáncer de endometrio buscan participantes en centros de Minneapolis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ReclutandoFase 3
- Abbott-Northwestern Hospital, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · A 5 mi de distancia
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
ReclutandoFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
ReclutandoFase 3
- Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
ReclutandoFase 3
- USOR - Minnesota Oncology/ Minneapolis Clinic, Minneapolis
- USOR - Minnesota Oncology, Minneapolis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
ReclutandoFase 3
- Research Site, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
ReclutandoFase 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ReclutandoFase 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Minneapolis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 518, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
ReclutandoFase 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Allina Health Cancer Institute, Minneapolis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
ReclutandoFase 2/3
- Minnesota Oncology Hematology, P.A., Minneapolis
Ensayos de Cáncer de endometrio en otras ciudades
- Houston, TX68 estudios
- New York City, NY52 estudios
- Boston, MA50 estudios
- Arlington, VA39 estudios
- Nashville, TN38 estudios
- Los Angeles, CA34 estudios
- St. Louis, MO29 estudios
- Philadelphia, PA28 estudios
- San Antonio, TX27 estudios
- Columbus, OH25 estudios
- Chicago, IL25 estudios
- Oklahoma City, OK25 estudios
Otros estudios en Minneapolis
- Cáncer de pulmón de células no pequeñas27 estudios
- Cáncer de seno27 estudios
- Cáncer de ovario24 estudios
- Cáncer de próstata23 estudios
- Cáncer (todos los tipos)22 estudios
- Fallo cardíaco21 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de pulmón20 estudios
- Cáncer del colon y del recto19 estudios
- Enfermedad de Parkinson17 estudios
- Enfermedad cardiovascular15 estudios
- Enfermedad de las arterias coronarias13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.